Japan is creating access to new treatments for neglected diseases
Dr. Mandeep Dhaliwal is director of the HIV and health group at the U.N. Development Program. Dr. Osamu Kunii is chief executive of the Tokyo-based Global Health Innovative Technology Fund.
Too often, a new, game-changing medicine emerges from rigorous research and clinical development, secures regulatory approval and then encounters significant implementation delays before reaching the people and communities who need it most.
Related News
